Patent · US Active

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

US8173671B2 · kind B2 · utility

2Cited by
8References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2010
Grant dateMay 8, 2012
Priority date—
Expiry dateJan 1, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Topical ophthalmic and otic solution compositions of moxifloxacin and dexamethasone phosphate are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.